Skip to content

Efficacy and Safety of Long-Pulse Nd:YAG Laser in the Treatment of Meibomian Gland Dysfunction (MGD) and Periocular Aesthetic Improvement

Efficacy and Safety of Long-Pulse Nd:YAG Laser in the Treatment of Meibomian Gland Dysfunction (MGD) and Periocular Aesthetic Improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114443
Enrollment
Unknown
Registered
2025-12-11
Start date
2024-02-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

Before-and-after comparison:Fotona 4D PIANO-mode Periocular Laser Therapy

Sponsors

School of Ophthalmology $ Optometry and Eye Hospital, Wenzhou Medical University, 270 Xueyuan Road, PR China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Dry eye patients aged 18-60 years old who attended the hospital with laser periocular treatment in the Plastic Department of Building 1 and diagnosed binocular MGD according to the Chinese expert consensus on meibomian gland dysfunction: diagnosis and treatment (2023) criteria, voluntarily participated in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Previous history of other eye diseases and ocular surgery other than refractive error (2) History of continuous systemic or ocular topical medication other than artificial tears within 3 months (3) History of laser therapy within 1 year (4) Pregnancy or lactation (5) Patients with photosensitive skin and other patients who are not suitable for laser treatment

Design outcomes

Primary

MeasureTime frame
Meibomian Gland Dysfunction (MGD) Grading Score;Lipid layer thickness;

Secondary

MeasureTime frame
Tear B;Ocular Surface Disease Index;Tear Meniscus Height;

Countries

China

Contacts

Public ContactHu Liang

School of Ophthalmology & Optometey and Eye Hospital, Wenzhou Medical University, 270

huliang@eye.ac.cn+86 138 6771 0883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026